VIEN GUT MODEL
Integrated Outpatient Care for Complex Chronic Multimorbidity
DOCUMENT A.4 — OPERATIONAL CONCEPT SET [2]
Nguyen Dinh Quang — Vien gut Model [2]
March 2026 — Ho Chi Minh City, Vietnam [2]
A.4 is the central reference document: any international reviewer encountering a HOW term in any document from A.0 to C.4 can consult A.4 to find an accurate, consistent definition with international cross-references [2]. A total of 35 terms, categorized into 3 groups by origin [2, 5]:
| Group | Group Name | Characteristics [5] |
|---|---|---|
| A | Existing international terms (7) | Uses correct international definitions, applied to LMIC multimorbidity [5] |
| B | Equivalent meaning terms (18) | Has equivalent concepts; Vien gut provides more specific operational interpretations [5] |
| C | Vien gut-developed terms (35 total) | Developed from 18 years of practice — no equivalent in existing literature [5] |
Three compiling rules: (1) Transparency of origin; (2) Operational definition; (3) International comparison [5].
7 core terms: Treat-to-target (T2T), Crystal-free, Multimorbidity, Risk stratification, Integrated care, Chronic Care Model (CCM), Real-World Evidence (RWE). Vien gut does not change the meaning, only applies them to the context of complex chronic multimorbidity in LMICs [6]. Notable point: T2T is extended and applied simultaneously across four axes (gout, kidney, heart, liver); integrated multi-axial risk stratification (T1–T4) instead of individual diseases [6].
| Vien gut Term | International Comparison and Differences [7, 8] |
|---|---|
| HOW gap | Closest: WHO ‘know-do gap’, Implementation Science ‘implementation gap’. VG emphasizes: lack of operational structure, not lack of motivation or knowledge [7]. |
| Clinical Conductor | Closest: CCM ‘care coordinator’, WHO ‘case manager’. VG emphasizes: proactive coordination, decision-making authority for cross-guideline priorities, SLA 24–48h [7]. |
| DATA-to-operate | Closest: ‘actionable data’, ‘decision-relevant data’. VG distinguishes: not research data or EMR — but data that triggers immediate clinical decisions [8]. |
| Monitoring SLA | SLA from ITIL service management. VG transferred into chronic outpatient care: 4 levels (4h/12h/24h/48h), not yet in outpatient literature [8]. |
| Phased treatment plan | Closest: ‘phased treatment’ in oncology. VG expands: 4 phases across four simultaneous multimorbidity axes [8]. |
| Term | Summary Operational Definition [9-11] |
|---|---|
| Clinical blind zone | Areas where patients need treatment but are not covered by guidelines — because evidence was designed for a different reference frame [9]. |
| Double blind zone | Two guidelines for two comorbidities are both silent on the intersection — the deepest blind zone [9]. |
| Guideline paradox | Doing the right thing for each individual disease guideline but being collectively wrong for the multimorbidity patient — due to a shift in the reference frame [9]. |
| Referral safety valve | Pre-defined clinical thresholds that trigger referral according to SLA — without waiting for the next visit [9]. |
| Clinical priority map | A tool to determine priority order when single-disease guidelines conflict for the same patient [10]. |
| Window of opportunity (operational) | Longitudinal monitoring state: 4 layers (outpatient safety / HOW implementation / DATA sufficiency / outcome anchor). Assessment: still open / closing / closed [10]. |
| Sensor–response system | Continuously operating MDT: each component both senses and responds, with 7 operational chain roles [10]. |
| Caliper mm² | Measuring urate crystals with digital calipers (mm²) — developed 9 years before OMERACT 0–3 [10]. |
| Conflict resolution matrix | Matrix tool to support adjudication when guidelines have opposing requirements for the same patient [10]. |
| Visual Medicine | Standardized clinical images/videos = operational data + compliance tools + verifiable evidence [11]. |
Strategic Argument: Clinical blind zones exist not because medicine lacks evidence — but because evidence is generated in a reference frame different from the reality of complex patients. Vien gut builds a new reference frame: blind zone mapping + integrated outpatient operational layer — shifting from ‘individual capacity-dependent treatment’ to ‘treatment based on structured system capacity, data, and safety valves’ [11].
A.4 is the central reference for the entire document set A.0–C.4. Main links: A.1 (EBM framework), A.2 (three-layer definition), A.3 (gap evidence), B.1–B.5 (operations), and C.1–C.4 (verification targets). A.5 (standardized glossary) adds a bilingual quick-reference table [12].
FitzGerald JD, et al. 2020 ACR Guideline for Gout [12].
Richette P, et al. 2016 EULAR recommendations for gout [12].
WHO. Framework on Integrated, People-centred Health Services. 2016 [13].
Barnett K, et al. Epidemiology of multimorbidity. Lancet. 2012 [13].
Wagner EH, et al. Improving chronic illness care. 2001 [13].
Eccles MP, Mittman BS. Welcome to Implementation Science. 2006 [13].
Tinetti ME, et al. Pitfalls of disease-specific guidelines. NEJM. 2004 [13].
Terslev L, et al. Ultrasound as outcome measure in gout — OMERACT. 2015 [13].
Electronic information portal providing specialized services (medicine and science & technology) of Vien Gut Company Limited. Compliant with Article 24, Clause 2 of Decree No. 147/2024/ND-CP, GDPR, and CCPA/CPRA.
Navigation
Policy